Respil en es it fr

Respil Brand names, Respil Analogs

Respil Brand Names Mixture

  • No information avaliable

Respil Chemical_Formula


Respil RX_link

Respil fda sheet

Respil FDA

Respil msds (material safety sheet)

Respil MSDS

Respil Synthesis Reference

No information avaliable

Respil Molecular Weight

198.216 g/mol

Respil Melting Point

78.5 oC

Respil H2O Solubility

50 mg/mL

Respil State


Respil LogP


Respil Dosage Forms

Liquid; Powder for solution; Syrup; Tablet

Respil Indication

Used to assist the expectoration of phlegm from the airways in acute respiratory tract infections.

Respil Pharmacology

Guaifenesin is an expectorant which increases the output of phlegm (sputum) and bronchial secretions by reducing adhesiveness and surface tension. The increased flow of less viscous secretions promotes ciliary action and changes a dry, unproductive cough to one that is more productive and less frequent. By reducing the viscosity and adhesiveness of secretions, guaifenesin increases the efficacy of the mucociliary mechanism in removing accumulated secretions from the upper and lower airway.

Respil Absorption

Rapidly absorbed from the GI tract

Respil side effects and Toxicity

LD50 1510 mg/kg (rat, oral)

Respil Patient Information

No information avaliable

Respil Organisms Affected

Humans and other mammals